
Sign up to save your podcasts
Or
Miyabe is the Chief Scientific Officer at Real Isolates. They have a background in pharmacology eicosanoids, endocannabinoids, synthetic cannabinoids, and phytocannabinoids. Their current project is focused on bringing biochemical validation and formulation to traditional plant-based medicines, specifically the composition of medicinal smoke; exploring how they can optimize formulations for therapeutic gain for chronic conditions. They believe that the interaction of cannabis and the brain can be pivotal to quality of life, especially in the context of neurodiversity. They says that cannabis saved their life, and they believes in the molecular basis of cannabis as a valid therapeutic option for chronic, neurological, inflammatory, and autoimmune disorders.
Riley's a natural product chemist with my Ph.D. in pharmaceutical sciences. Their research interests have broadly focused on the use of medicinal plants in combating antibiotic resistance and alternative pain treatments to opiates.
Their current research interests focus on characterizing the transformation and rearrangement of Cannabis secondary metabolites during the smoking process and how they can better predict what pharmacological effects this leads to.
They are passionate about providing free and accessible Cannabis education to all users, mainly through social media channels. More education will facility safer consumption methods, laboratory testing, and transparency.
Forbes Article-
Podcast-
Smokenol- Smoke N' Science Podcast
Dr. Miyabe Shields, PhD
LinkedIn
Instagram
TikTok
Dr. Riley Kirk, PhD
LinkedIn
TikTok
YouTube
Instagram
Support the show
5
66 ratings
Miyabe is the Chief Scientific Officer at Real Isolates. They have a background in pharmacology eicosanoids, endocannabinoids, synthetic cannabinoids, and phytocannabinoids. Their current project is focused on bringing biochemical validation and formulation to traditional plant-based medicines, specifically the composition of medicinal smoke; exploring how they can optimize formulations for therapeutic gain for chronic conditions. They believe that the interaction of cannabis and the brain can be pivotal to quality of life, especially in the context of neurodiversity. They says that cannabis saved their life, and they believes in the molecular basis of cannabis as a valid therapeutic option for chronic, neurological, inflammatory, and autoimmune disorders.
Riley's a natural product chemist with my Ph.D. in pharmaceutical sciences. Their research interests have broadly focused on the use of medicinal plants in combating antibiotic resistance and alternative pain treatments to opiates.
Their current research interests focus on characterizing the transformation and rearrangement of Cannabis secondary metabolites during the smoking process and how they can better predict what pharmacological effects this leads to.
They are passionate about providing free and accessible Cannabis education to all users, mainly through social media channels. More education will facility safer consumption methods, laboratory testing, and transparency.
Forbes Article-
Podcast-
Smokenol- Smoke N' Science Podcast
Dr. Miyabe Shields, PhD
LinkedIn
Instagram
TikTok
Dr. Riley Kirk, PhD
LinkedIn
TikTok
YouTube
Instagram
Support the show